229 related articles for article (PubMed ID: 28449430)
1. Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma.
Li S; Xiong Y; Zhang X
Biomed Pharmacother; 2017 Jun; 90():872-879. PubMed ID: 28449430
[TBL] [Abstract][Full Text] [Related]
2. Inclusion of a pH-responsive amino acid-based amphiphile in methotrexate-loaded chitosan nanoparticles as a delivery strategy in cancer therapy.
Nogueira DR; Scheeren LE; Macedo LB; Marcolino AI; Pilar Vinardell M; Mitjans M; Rosa Infante M; Farooqi AA; Rolim CM
Amino Acids; 2016 Jan; 48(1):157-68. PubMed ID: 26306845
[TBL] [Abstract][Full Text] [Related]
3. Ceramic core with polymer corona hybrid nanocarrier for the treatment of osteosarcoma with co-delivery of protein and anti-cancer drug.
Prasad SR; Kumar TSS; Jayakrishnan A
Nanotechnology; 2018 Jan; 29(1):015101. PubMed ID: 29130895
[TBL] [Abstract][Full Text] [Related]
4. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
[TBL] [Abstract][Full Text] [Related]
6. Poloxamer 407 based-nanoparticles for controlled release of methotrexate.
Moura S; Noro J; Cerqueira P; Silva C; Cavaco-Paulo A; Loureiro A
Int J Pharm; 2020 Feb; 575():118924. PubMed ID: 31870962
[TBL] [Abstract][Full Text] [Related]
7. A micelle-like structure of poloxamer-methotrexate conjugates as nanocarrier for methotrexate delivery.
Ren J; Fang Z; Yao L; Dahmani FZ; Yin L; Zhou J; Yao J
Int J Pharm; 2015 Jun; 487(1-2):177-86. PubMed ID: 25865570
[TBL] [Abstract][Full Text] [Related]
8. N,N,N-trimethyl chitosan embedded in situ Pluronic F127 hydrogel for the treatment of brain tumor.
Turabee MH; Jeong TH; Ramalingam P; Kang JH; Ko YT
Carbohydr Polym; 2019 Jan; 203():302-309. PubMed ID: 30318217
[TBL] [Abstract][Full Text] [Related]
9. Polyamidoamine dendrimer conjugated chitosan nanoparticles for the delivery of methotrexate.
Leng ZH; Zhuang QF; Li YC; He Z; Chen Z; Huang SP; Jia HY; Zhou JW; Liu Y; Du LB
Carbohydr Polym; 2013 Oct; 98(1):1173-8. PubMed ID: 23987460
[TBL] [Abstract][Full Text] [Related]
10. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
11. In vivo pharmacological evaluation and efficacy study of methotrexate-encapsulated polymer-coated layered double hydroxide nanoparticles for possible application in the treatment of osteosarcoma.
Ray S; Saha S; Sa B; Chakraborty J
Drug Deliv Transl Res; 2017 Apr; 7(2):259-275. PubMed ID: 28050892
[TBL] [Abstract][Full Text] [Related]
12. Multi-functionalized chitosan nanoparticles for enhanced chemotherapy in lung cancer.
Guo X; Zhuang Q; Ji T; Zhang Y; Li C; Wang Y; Li H; Jia H; Liu Y; Du L
Carbohydr Polym; 2018 Sep; 195():311-320. PubMed ID: 29804982
[TBL] [Abstract][Full Text] [Related]
13. Combinational delivery of anticancer drugs for osteosarcoma treatment using electrosprayed core shell nanocarriers.
Prasad SR; Jayakrishnan A; Kumar TSS
J Mater Sci Mater Med; 2020 May; 31(5):44. PubMed ID: 32367204
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and formulation of methotrexate (MTX) conjugated LaF3:Tb(3+)/chitosan nanoparticles for targeted drug delivery applications.
Mangaiyarkarasi R; Chinnathambi S; Aruna P; Ganesan S
Biomed Pharmacother; 2015 Feb; 69():170-8. PubMed ID: 25661354
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate-incorporated polymeric nanoparticles of methoxy poly(ethylene glycol)-grafted chitosan.
Seo DH; Jeong YI; Kim DG; Jang MJ; Jang MK; Nah JW
Colloids Surf B Biointerfaces; 2009 Mar; 69(2):157-63. PubMed ID: 19135342
[TBL] [Abstract][Full Text] [Related]
16. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
17. In-vivo tumor targeting of pluronic-based nano-carriers.
Kim JY; Choi WI; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
J Control Release; 2010 Oct; 147(1):109-17. PubMed ID: 20600404
[TBL] [Abstract][Full Text] [Related]
18. A mechanistic investigation on methotrexate-loaded chitosan-based hydrogel nanoparticles intended for CNS drug delivery: Trojan horse effect or not?
Pourtalebi Jahromi L; Moghaddam Panah F; Azadi A; Ashrafi H
Int J Biol Macromol; 2019 Mar; 125():785-790. PubMed ID: 30543880
[TBL] [Abstract][Full Text] [Related]
19. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.
Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X
Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
